Malignant cancer is a growth of abnormal cells that can invade nearby tissues and spread to distant parts of the body. This ability to spread, called metastasis, is what separates malignant tumors from benign ones, which stay contained in one location and rarely threaten life. In 2022, an estimated 20 million new malignant cancer cases were diagnosed worldwide, with 9.7 million deaths.
What Makes a Tumor Malignant
Every tumor is a mass of cells that have started dividing in an uncontrolled way. But not every tumor is cancer. Benign tumors grow in place, stay within clear boundaries, and don’t invade the tissue around them. Malignant tumors do the opposite: they push into surrounding tissue, break through barriers, and can eventually travel to organs far from where they started.
At the cellular level, malignancy comes down to a breakdown in the checks and balances that normally control cell growth. Healthy cells have two key types of genes working in opposition. One type promotes cell division and survival, while the other acts as a brake, controlling growth and triggering cell death when something goes wrong. When mutations or other genetic changes tip the balance, favoring growth genes and disabling the brakes, a cell can begin multiplying without limits. That’s the foundation of malignant transformation.
If you feel a lump, there are some physical clues that point toward malignancy. Cancerous tumors tend to feel firm and relatively fixed in place, while benign lumps or cysts are more likely to feel soft and movable. These are rough guidelines, though, not a diagnosis. Only a tissue sample examined under a microscope can confirm whether a growth is malignant.
How Malignant Cells Spread
Metastasis is a multi-step process. First, malignant cells invade the normal tissue immediately surrounding the tumor. They then push through the walls of nearby blood vessels or lymph channels. Once inside those systems, cancer cells travel through the bloodstream or lymphatic fluid until they lodge in small blood vessels at a new location. There, they break through the vessel wall again, settle into the surrounding tissue, and begin forming a new tumor.
To keep growing, both the original tumor and any new deposits need a blood supply. Malignant tumors solve this by releasing chemical signals that cause nearby blood vessels to sprout new branches toward the tumor. This process, called angiogenesis, delivers oxygen and nutrients to the growing mass. When a tumor outgrows its blood supply and cells become starved of oxygen, they ramp up these signals even further, accelerating blood vessel formation. Blocking this blood vessel recruitment is one of the strategies used in modern cancer treatment.
Main Types of Malignant Cancer
Malignant cancers are classified by the type of tissue where they originate:
- Carcinomas start in epithelial tissue, the cells that line your organs, skin, and internal surfaces. These are by far the most common cancers and include breast, lung, colon, and prostate cancers.
- Sarcomas arise in connective and supportive tissues like bone, cartilage, muscle, fat, and tendons.
- Leukemias are cancers of the bone marrow, where blood cells are produced. They’re sometimes called blood cancers or liquid cancers because they don’t form solid tumors.
- Lymphomas develop in the lymphatic system, part of the body’s immune network.
- Myelomas originate in plasma cells, a type of immune cell found in bone marrow.
A cancer is always named for its tissue of origin, even after it spreads. Breast cancer that metastasizes to the lungs is still breast cancer, not lung cancer, because the cells retain the characteristics of the original tissue.
What Causes Cells to Become Malignant
There is rarely a single cause. Malignant transformation typically results from accumulated damage to a cell’s DNA over time. That damage can come from chemical carcinogens (like those in tobacco smoke), physical exposures (like UV radiation from the sun or X-rays), or biological agents (like certain viruses). Inherited genetic mutations can also give someone a head start down this path, though most cancers develop from damage acquired during a person’s lifetime.
The International Agency for Research on Cancer has identified ten characteristics commonly shared by known carcinogens. These include the ability to directly damage DNA, interfere with DNA repair, trigger chronic inflammation, suppress immune function, and alter normal patterns of cell growth and death. A substance doesn’t need all ten traits to be dangerous. Even one or two, sustained over time, can push cells toward malignancy.
Symptoms That Can Signal Malignancy
Malignant cancers can produce both local and whole-body symptoms. Local symptoms depend on where the tumor is: a lung tumor might cause a persistent cough, while a colon tumor might cause changes in bowel habits or blood in the stool.
Systemic symptoms are more general and result from the body’s inflammatory response to the cancer. Unexplained weight loss is one of the most recognized warning signs. More than half of people with advanced cancer experience pain, fatigue, weakness, and loss of appetite. In later stages, a condition called cachexia can develop, where the body wastes away despite adequate food intake. Cachexia is driven by inflammatory chemicals released by both the tumor and the immune system, and it contributes significantly to physical decline. Night sweats, persistent fevers, and increasing fatigue without a clear explanation are other systemic signs worth taking seriously.
How Malignant Cancer Is Diagnosed
Diagnosis starts with imaging (scans, X-rays, ultrasounds) to locate and measure a suspicious growth, but the definitive step is a biopsy. A pathologist examines tissue under a microscope, looking at cell shape, size, and arrangement. Malignant cells look visibly abnormal: they vary in size and shape, their internal structures are disorganized, and they show signs of rapid, chaotic division. The pathologist assigns a tumor grade based on how abnormal the cells appear. Higher-grade tumors look less like normal tissue and tend to grow more aggressively.
Additional tests may measure specific markers on the surface of cancer cells, which can reveal the cancer’s subtype and help guide treatment decisions. These markers can indicate whether a tumor is likely to respond to targeted therapies.
Staging: How Far It Has Spread
Once malignancy is confirmed, staging determines how far the cancer has progressed. The most widely used system assigns three scores. T describes the size and extent of the primary tumor, on a scale from T1 (small) to T4 (large or deeply invasive). N indicates whether cancer has reached nearby lymph nodes, from N0 (none) to N3 (many involved). M records whether the cancer has metastasized to distant organs: M0 means it hasn’t, M1 means it has.
These three scores combine into an overall stage, typically expressed as stage I through IV. Stage I cancers are small and localized. Stage IV means the cancer has spread to distant parts of the body. Staging matters enormously for prognosis. For colorectal cancer, as one example, the five-year survival rate for localized disease is about 90 to 91%. When the same cancer has spread to distant organs, that drops to 13 to 18%. This pattern holds across most cancer types: early detection, while the tumor is still localized, dramatically improves outcomes.
How Malignant Cancer Is Treated
Treatment depends on the cancer type, its stage, its molecular characteristics, and the patient’s overall health. The core approaches are surgery to remove the tumor, radiation to destroy cancer cells in a targeted area, and drug therapies that work throughout the body. These drug therapies include traditional chemotherapy, which kills rapidly dividing cells, and newer targeted treatments that attack specific vulnerabilities in cancer cells or cut off their blood supply.
Immunotherapy, which helps the immune system recognize and attack cancer cells, has become a major treatment category over the past decade. For some cancers, it has produced durable remissions even in advanced disease. Treatment plans often combine multiple approaches. Someone might have surgery followed by chemotherapy to eliminate any remaining cells, or radiation combined with immunotherapy.
Some malignant cancers are curable, particularly when caught early and removed completely with surgery. Others are managed as chronic conditions, kept in check for years with ongoing treatment. The trajectory varies widely. A small, localized skin cancer might be cured in a single office visit, while a metastatic pancreatic cancer presents one of the most difficult challenges in medicine. The word “malignant” covers an enormous range of diseases with very different behaviors and outlooks.